Pages that link to "Q45015016"

The following pages link to Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease (Q45015016):

Displaying 25 items.

• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease (Q24187361) (← links)
• Exacerbations of COPD (Q26764891) (← links)
• Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients (Q27010596) (← links)
• Corticosteroid therapy in critical illness due to seasonal and pandemic influenza (Q30379936) (← links)
• Risk factors for physical impairment after acute lung injury in a national, multicenter study (Q33772265) (← links)
• Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD (Q35683454) (← links)
• Pharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients (Q37372207) (← links)
• Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients. (Q38511557) (← links)
• High-Dose Versus Low-Dose Systemic Steroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Systematic Review (Q38604638) (← links)
• Update in Chronic Obstructive Pulmonary Disease 2014. (Q38620368) (← links)
• A Survey of Corticosteroid Dosing for Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Assisted Ventilation (Q40067048) (← links)
• Relationship of Steroid Dosing and Duration of Mechanical Ventilation in Adult Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Q40242815) (← links)
• A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models. (Q40397150) (← links)
• Tailoring of corticosteroids in COPD management (Q42753079) (← links)
• Impact and prevention of severe exacerbations of COPD: a review of the evidence (Q45803920) (← links)
• An Observational Study of the Efficacy of Cisatracurium Compared to Vecuronium in Patients with or at Risk for ARDS. (Q47309841) (← links)
• Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill Patients (Q47434454) (← links)
• Evaluation of Corticosteroid Dose in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. (Q49586989) (← links)
• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. (Q52649183) (← links)
• Management of severe acute exacerbations of COPD: an updated narrative review (Q57298307) (← links)
• Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism (Q89443801) (← links)
• The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis (Q95008282) (← links)
• Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis (Q91827956) (← links)
• Downregulated level of insulin in COPD patients during AE; role beyond glucose control? (Q92603741) (← links)
• Steroid-Induced Sleep Disturbance and Delirium: A Focused Review for Critically Ill Patients (Q97569668) (← links)